Bispecific Antibody Therapy in Cancer Care – What Acute Care Physicians Need to Know for Safe Administration
Bispecific Antibody Therapy in Cancer Care – What Acute Care Physicians Need to Know for Safe Administration
Thursday, September 12 | 5:30 – 7:00 pm
A panel of cancer experts will delve into crucial information and insights on Bispecific Antibody Therapy. Learn more about bispecific antibodies’ role in cancer management, how to describe inpatient (and subsequent outpatient) administration of bispecific antibodies and more.
By the end of this session, participants will be able to:
- Identify bispecific antibodies, a new class of immunotherapy, and their role in cancer management;
- Describe inpatient (and subsequent outpatient) administration of bispecific antibodies;
- Recognize bispecific antibody-related toxicities including cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome; and
- Demonstrate an approach to the management of bispecific antibody-related toxicities.
Speakers
Dr. Azadeh Arjmandi, Family Physician, GPO
Dr. Alina Gerrie, Hematologist
Moderator: Dr. Sian Shuel, Family Physician, GPO, Medical Education Lead, Family Practice Oncology Network